These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2556308)
1. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency. Tuvemo T; Dahlquist G; Frisk G; Blom L; Friman G; Landin-Olsson M; Diderholm H Diabetologia; 1989 Oct; 32(10):745-7. PubMed ID: 2556308 [TBL] [Abstract][Full Text] [Related]
2. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. King ML; Shaikh A; Bidwell D; Voller A; Banatvala JE Lancet; 1983 Jun; 1(8339):1397-9. PubMed ID: 6134178 [TBL] [Abstract][Full Text] [Related]
3. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Banatvala JE; Bryant J; Schernthaner G; Borkenstein M; Schober E; Brown D; De Silva LM; Menser MA; Silink M Lancet; 1985 Jun; 1(8443):1409-12. PubMed ID: 2861361 [TBL] [Abstract][Full Text] [Related]
4. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Frisk G; Friman G; Tuvemo T; Fohlman J; Diderholm H Diabetologia; 1992 Mar; 35(3):249-53. PubMed ID: 1314203 [TBL] [Abstract][Full Text] [Related]
5. High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity. Frisk G; Fohlman J; Kobbah M; Ewald U; Tuvemo T; Diderholm H; Friman G J Med Virol; 1985 Nov; 17(3):219-27. PubMed ID: 2999322 [TBL] [Abstract][Full Text] [Related]
6. IgM against Coxsackie B viruses in children developing type I diabetes mellitus--a seven-year retrospective study. Tuvemo T; Frisk G; Friman G; Ludvigsson J; Diderholm H Diabetes Res; 1988 Nov; 9(3):125-9. PubMed ID: 2854031 [TBL] [Abstract][Full Text] [Related]
7. The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. Frisk G; Nilsson E; Tuvemo T; Friman G; Diderholm H J Infect; 1992 Jan; 24(1):13-22. PubMed ID: 1312561 [TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes. Mertens T; Grüneklee D; Eggers HJ Eur J Pediatr; 1983 Sep; 140(4):293-4. PubMed ID: 6313373 [TBL] [Abstract][Full Text] [Related]
9. An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Friman G; Fohlman J; Frisk G; Diderholm H; Ewald U; Kobbah M; Tuvemo T Acta Paediatr Scand Suppl; 1985; 320():14-9. PubMed ID: 3010631 [TBL] [Abstract][Full Text] [Related]
11. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. D'Alessio DJ Am J Epidemiol; 1992 Jun; 135(12):1331-8. PubMed ID: 1324601 [TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes and Coxsackie virus infection. Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095 [TBL] [Abstract][Full Text] [Related]
13. Antibody responses to different strains of coxsackie B4 virus in patients with newly diagnosed type I diabetes mellitus or aseptic meningitis. Frisk G; Diderholm H J Infect; 1997 May; 34(3):205-10. PubMed ID: 9200026 [TBL] [Abstract][Full Text] [Related]
14. Heterotypic reactions in a radioimmunoassay for coxsackie B virus specific IgM. Pugh SF J Clin Pathol; 1984 Apr; 37(4):433-9. PubMed ID: 6323548 [TBL] [Abstract][Full Text] [Related]
15. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Dahlquist G; Frisk G; Ivarsson SA; Svanberg L; Forsgren M; Diderholm H Diabetologia; 1995 Nov; 38(11):1371-3. PubMed ID: 8582549 [TBL] [Abstract][Full Text] [Related]
16. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. El-Hagrassy MM; Banatvala JE; Coltart DJ Lancet; 1980 Nov; 2(8205):1160-2. PubMed ID: 6107769 [TBL] [Abstract][Full Text] [Related]
17. [The role of coxsackie virus infection in the development of type 1 diabetes mellitus and its effect on the postinitial course of the disease in childhood]. Michalková D; Petrovicová A; Kolár J; Jancová E; Sílesová J Cesk Pediatr; 1989 May; 44(5):257-62. PubMed ID: 2752452 [TBL] [Abstract][Full Text] [Related]
18. Coxsackie B virus antibody responses in juvenile-onset diabetes mellitus. Ray CG; Palmer JP; Crossley JR; Williams RH Clin Endocrinol (Oxf); 1980 Apr; 12(4):375-8. PubMed ID: 6247107 [TBL] [Abstract][Full Text] [Related]
19. Humoral immunity against viral antigens in type 1 diabetes: altered IgA-class immune response against Coxsackie B4 virus. Hyöty H; Huupponen T; Kotola L; Leinikki P Acta Pathol Microbiol Immunol Scand C; 1986 Apr; 94(2):83-8. PubMed ID: 2426921 [TBL] [Abstract][Full Text] [Related]
20. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection. Palmer JP; Cooney MK; Ward RH; Hansen JA; Brodsky JB; Ray CG; Crossley JR; Asplin CM; Williams RH Diabetologia; 1982 Jun; 22(6):426-9. PubMed ID: 6286394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]